Lexaria Bioscience (LEXX) Q2 2026 Earnings

13JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Q2 2026
-0.16
-0.13
-0.09
-0.06

Details

Expected EPS
-0.06
Actual EPS
-0.08
Surprise EPS
-0.02
Surprise Percent
+33.33%

Description

Lexaria Bioscience (LEXX) has reported earnings of -0.08 per share for Q2 2026.

0 Comments

Share your thoughts